Distributed approximately 94,000 SYFOVRE doses (commercial and sample vials ... Submission of a supplemental new drug application (sNDA) expected in early 2025 for C3G and primary IC-MPGN ...

Archaeologists have traced the earliest case of lead pollution by humans to the Aegean Sea region around 5,200 years ago. The findings, published in the journal Communications Earth & Environment, ...

Rising awareness, innovative therapies, and evolving treatment options drive this growth.

Distributed approximately 94,000 SYFOVRE doses (commercial and sample vials) to physician practices in 4Q 2025 ... in nephrology Submission of a supplemental new drug application (sNDA) expected in ...

Days into Oval Office, Donald Trump took major decisions including imposing 25% Tariffs on all Mexican and Canadian goods. As ...

Welireg's sNDA for advanced PPGL treatment is under FDA priority review, potentially becoming the first U.S. therapy for this condition. The LITESPARK-015 trial supports the sNDA with ORR and DOR data ...

Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...

Scilex (SCLX) announced that it will be filing today of a Supplemental New Drug Application, SNDA, with the FDA for ELYXYB in acute pain indication. “We are well positioned to broaden the ELYXYB ...

(RTTNews) - Johnson & Johnson (JNJ), Tuesday announced that the U.S. Food and Drug Administration has approved supplemental New Drug Application or sNDA for Spravato, a monotherapy for adults with ...